Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group‐Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the Future

Documenti analoghi

• Innovations and Best Practices for Therapeutic Development in Pediatric Rare Diseases: A Model‐Informed Drug Development Perspective
  di: Rajesh Krishna, et al.
  Pubblicazione: (2025)
• The Rare Disease Moonshot: Paradigms Shift, Translational Medicine, and Regulatory Science for the World's Rarest Conditions
  di: Cécile Ollivier, et al.
  Pubblicazione: (2024)
• New Horizons of Model Informed Drug Development in Rare Diseases Drug Development
  di: Amitava Mitra, et al.
  Pubblicazione: (2024)
• Quantitative Systems Pharmacology Models: Potential Tools for Advancing Drug Development for Rare Diseases
  di: Susana Neves‐Zaph, et al.
  Pubblicazione: (2024)
• Dose Optimization in Oncology Drug Development: An International Consortium for Innovation and Quality in Pharmaceutical Development White Paper
  di: Divya Samineni, et al.
  Pubblicazione: (2024)